당뇨망막병증으로 인한 황반부종에서 트리암시놀론 안내주입술 후 발생한 망막중심동맥폐쇄 1예

• 영문명: A Case of Central Retinal Artery Occlusion after Intravitreal Triamcinolone Acetonide Injection for Diabetic Macular Edema in Non-Proliferative Diabetic Retinopathy
• 발행기관: 대한안과학회
• 저자명: 신재호 김도균 유승영 곽형우,Jae Ho Shin, M.D., Do Kyun Kim, M.D., Seung Young Yu, M.D., Hyung Woo Kwak, M.D.
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume47,number4, 667~671쪽, 전체 5쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2006.04.30

영문 초록

Purpose: We report a case of central retinal artery occlusion after two intravitreal injections of triamcinolone acetonide for diabetic macular edema due to non-proliferative diabetic retinopathy. Methods: A forty-six year old man with a ten-year history of DM visited our clinic because of diminished vision in his right eye (0.02). He received intravitreal triamcinolone acetonide for diabetic macular edema due to NPDR. After injection, he showed recovery of visual acuity (0.9) and decrease of macular edema. After two months, he received a second intravitreal triamcinolone acetonide injection because his visual acuity had diminished during the two-month period. Fifteen days after the second injection, visual acuity of his right eye suddenly diminished to no light perception. At this time, we performed fundus photograph, fluorescein angiography, and optical coherence tomography. Results: From the fundus exam, we diagnosed the patient with CRAO and prescribed an antithrombotic agent. Five month after the occlusion, visual acuity of the right eye improved 0.3, but generalized sclerosis of retinal vessels was present. Eight months after the occlusion, however he developed neovascular glaucoma and visual acuity of the right eye fell to the light perception negative range. Conclusions: We experienced a case of central retinal artery occlusion after intravitreal triamcinolone acetonide injection. Therefore, possible vascular complications should be considered following this type of injection.

키워드

Central retinal artery occlusion, Diabetic macular edema, Interactional triamcinolone acetified injection, Non-proliferative diabetic retinopathy